PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 10387802

Pharmaceuticals. Plunder and pillage.

A Earl-Slater
View original source ↗Export metadata ↓

Abstract

The government has proposed a statutory scheme to regulate prices and profits on the sale of drugs to the NHS. Drug companies which don't cooperate could be liable to heavy fines, but the government has failed to spell out the precise conditions under which such penalties would apply. Defining what comprises excessive prices or profits is likely to present a number of empirical problems. Experience overseas suggests that the scheme will fail to halt the inexorable rise in the NHS drugs bill.

Explore related subjects

CommerceCost ControlDrug CostsDrug IndustryHumansInflation, EconomicState MedicineUnited KingdomJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A Earl-Slater. 1999-05-06. Pharmaceuticals. Plunder and pillage.. https://pubmed.ncbi.nlm.nih.gov/10387802/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

ACOG Committee Opinion No. 359: commercial enterprises in medical practice.

Increasing numbers of physicians sell and promote both medical and nonmedical products as part of their practices. Physicians always have rendered advice and treatment for a fee, and this practice is appropriate. It is unethical under most circumstances, however, for physicians to sell or promote medical or nonmedical products or services for their financial benefit. The following activities are considered unethical: sale of prescription drugs to be used at home, sale or promotion of nonprescription medicine, sale or promotion of presumptively therapeutic agents that generally are not accepted as part of standard medical practice, sale or promotion of non-health-related items, recruitment of patients or other health care professionals into multilevel marketing arrangements, and sale or promotion of any product in whose sale the physician has a significant financial interest. It is ethical and appropriate, however, to sell products to patients as follows: sale of devices or drugs that require professional administration in the office setting; sale of therapeutic agents, when no other facilities can provide them at reasonable convenience and at reasonable cost; sale of products that clearly are external to the patient-physician relationship, when such a sale would be considered appropriate in an external relationship; and sale of low-cost products for the benefit of community organizations. A rationale is provided for both the prohibited activities and exceptions.

Commerce↗